Amniocentesis

Amniocentesis. It is a prenatal diagnostic procedure in which a small amount of amniotic fluid is extracted from the amniotic sac surrounding a developing fetus. The procedure is typically performed between the 15th and 20th weeks of gestation and is used to detect genetic abnormalities and other fetal conditions. The sampled fluid contains fetal cells and biochemical substances that can be analyzed for chromosomal, genetic, and neural tube defects.

Procedure

The procedure is usually performed on an outpatient basis, often guided by continuous ultrasound imaging to visualize the position of the fetus and placenta. After cleansing the maternal abdomen, a local anesthetic may be administered before a thin, hollow needle is inserted through the abdominal wall and into the amniotic cavity. Approximately 20 milliliters of amniotic fluid is withdrawn into a syringe, after which the needle is removed. The fetal cells from the fluid are then cultured in a laboratory for several days to two weeks to enable karyotype analysis, a process that can be expedited with techniques like fluorescence in situ hybridization. Following the procedure, the patient is typically monitored for a short period, and activities may be restricted for 24-48 hours.

Indications and uses

Primary indications include advanced maternal age, typically over 35, which increases the risk for chromosomal anomalies such as Down syndrome, Edwards syndrome, and Patau syndrome. It is also recommended following an abnormal result from a screening test, such as the first-trimester screening or quad screen, or a concerning finding on a routine ultrasound. Furthermore, it is used when there is a family history or known carrier status for specific genetic disorders like cystic fibrosis, Tay-Sachs disease, or sickle cell disease, and to diagnose certain neural tube defects by measuring alpha-fetoprotein levels in the fluid. In some cases, later in pregnancy, it can assess fetal lung maturity or diagnose and treat conditions like Rh disease.

Risks and complications

While generally considered safe, the procedure carries a small risk of miscarriage, estimated at about 0.1% to 0.3% above the background rate. Other potential complications include leakage of amniotic fluid, vaginal bleeding, or uterine infection such as chorioamnionitis. There is a minimal risk of needle injury to the fetus, though this is greatly reduced with concurrent ultrasound guidance. Rarely, the procedure can lead to amniotic fluid embolism or sensitization in Rh-negative mothers, which is typically prevented with an injection of Rho(D) immune globulin. Patients are advised to report signs of fever, severe cramping, or fluid loss following the test.

Interpretation of results

Results from the cultured fetal cells provide a definitive karyotype, revealing the number and structure of chromosomes to diagnose conditions like trisomy 21 or Turner syndrome. Molecular genetic testing on the cells can identify specific single-gene disorders. The fluid itself is analyzed for levels of alpha-fetoprotein and acetylcholinesterase, which are elevated in open neural tube defects such as spina bifida or anencephaly. Normal results significantly reduce the likelihood of the tested conditions but do not guarantee a perfectly healthy baby, as the test does not screen for all possible birth defects. Abnormal results are typically discussed in detail by a genetic counselor alongside specialists from institutions like the American College of Obstetricians and Gynecologists.

Alternatives

Several alternative prenatal tests exist, including chorionic villus sampling, which can be performed earlier, between 10 and 13 weeks, but carries a slightly higher risk of miscarriage. Non-invasive prenatal testing analyzes cell-free fetal DNA from the maternal bloodstream to screen for common chromosomal conditions with no procedure-related risk, though it is a screening, not a diagnostic, test. Detailed ultrasound examinations, such as the nuchal translucency scan or anatomy scan, can identify physical abnormalities but not all genetic conditions. For some metabolic disorders, preimplantation genetic diagnosis during in vitro fertilization offers a very early diagnostic option before pregnancy is established.

Category:Prenatal diagnosis Category:Obstetrics Category:Medical tests